Thermo Fisher launches new test to assess lung transplant rejection
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Athena is also exploring the use of this technology for expanded carrier screening
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Subscribe To Our Newsletter & Stay Updated